-
(3R,4R)-(-)-1-苄基-3,4-吡咯烷二醇,163439-82-5,97%
-
化合物(4R,9S)-AG 205 T70835
-
(2S,4R)-H-L-Pro(4-N3)-OH hydrochloride | MedChemExpress (MCE)
-
(3R,4R)-3-氨基-1-Boc-4-羟基吡咯烷,330681-18-0,98%
-
(S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-N(Me)-Boc | MedChemExpress (MCE)
-
(2R,4R)-Boc-D-Pro(4-N3)-OH | MedChemExpress (MCE)
-
(4R)-(+)-异丙基-5,5-二苯基-2-噁唑烷酮,191090-32-1,98%
-
(3S,4R)-N-Boc-4-氨基-3-甲氧基哌啶,1171125-92-0,95%
-
2,2'-双((4R)-4-苄基-2-恶唑啉),141362-76-7,97% (99%ee)
2,2'-Bis[(4R)-4-Benzyl-2-Oxazoline]上海阿拉丁生化科技股份有限公司阿拉丁中国中文名:2,2'-双((4R)-4-苄基-2-恶唑啉)英文名:2,2'-Bis[(4R
-
(2S,4R)-Fmoc-L-Pro(4-N3)-OH | MedChemExpress (MCE)
想在此推广您的产品吗?
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net